Q Zeng1, B Jiang2, F Shi3, C Ling1, F Dong2, J Zhang4,5,6. 1. From the Departments of Neurosurgery (Q.Z., C.L., J.Z.). 2. Radiology (B.J., F.D.). 3. Neurology (F.S.), Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 4. From the Departments of Neurosurgery (Q.Z., C.L., J.Z.) zjm135@vip.sina.com. 5. Brain Research Institute (J.Z.). 6. Collaborative Innovation Center for Brain Science (J.Z.), Zhejiang University, Hangzhou, Zhejiang, China.
Abstract
BACKGROUND AND PURPOSE: Previous studies showed conflicting results concerning the value of CBF maps obtained from arterial spin-labeling MR imaging in grading gliomas. This study was performed to investigate the effectiveness of CBF maps derived from 3D pseudocontinuous arterial spin-labeling in preoperatively assessing the grade, cellular proliferation, and prognosis of gliomas. MATERIALS AND METHODS: Fifty-eight patients with pathologically confirmed gliomas underwent preoperative 3D pseudocontinuous arterial spin-labeling. The receiver operating characteristic curves for parameters to distinguish high-grade gliomas from low-grade gliomas were generated. Pearson correlation analysis was used to assess the correlation among parameters. Survival analysis was conducted with Cox regression. RESULTS: Both maximum CBF and maximum relative CBF were significantly higher in high-grade gliomas than in low-grade gliomas (P < .001). The areas under the curve for maximum CBF and maximum relative CBF in distinguishing high-grade gliomas from low-grade gliomas were 0.828 and 0.863, respectively. Both maximum CBF and maximum relative CBF had no correlation with the Ki-67 index in all subjects and had a moderate negative correlation with the Ki-67 index in glioblastomas (r = -0.475, -0.534, respectively). After adjustment for age, a higher maximum CBF (P = .008) and higher maximum relative CBF (P = .005) were associated with worse progression-free survival in gliomas, while a higher maximum relative CBF (P = .033) was associated with better overall survival in glioblastomas. CONCLUSIONS: 3D pseudocontinuous arterial spin-labeling-derived CBF maps are effective in preoperative evaluation of gliomas. Although gliomas with a higher blood flow are more malignant, glioblastomas with a lower blood flow are likely to be more aggressive.
BACKGROUND AND PURPOSE: Previous studies showed conflicting results concerning the value of CBF maps obtained from arterial spin-labeling MR imaging in grading gliomas. This study was performed to investigate the effectiveness of CBF maps derived from 3D pseudocontinuous arterial spin-labeling in preoperatively assessing the grade, cellular proliferation, and prognosis of gliomas. MATERIALS AND METHODS: Fifty-eight patients with pathologically confirmed gliomas underwent preoperative 3D pseudocontinuous arterial spin-labeling. The receiver operating characteristic curves for parameters to distinguish high-grade gliomas from low-grade gliomas were generated. Pearson correlation analysis was used to assess the correlation among parameters. Survival analysis was conducted with Cox regression. RESULTS: Both maximum CBF and maximum relative CBF were significantly higher in high-grade gliomas than in low-grade gliomas (P < .001). The areas under the curve for maximum CBF and maximum relative CBF in distinguishing high-grade gliomas from low-grade gliomas were 0.828 and 0.863, respectively. Both maximum CBF and maximum relative CBF had no correlation with the Ki-67 index in all subjects and had a moderate negative correlation with the Ki-67 index in glioblastomas (r = -0.475, -0.534, respectively). After adjustment for age, a higher maximum CBF (P = .008) and higher maximum relative CBF (P = .005) were associated with worse progression-free survival in gliomas, while a higher maximum relative CBF (P = .033) was associated with better overall survival in glioblastomas. CONCLUSIONS: 3D pseudocontinuous arterial spin-labeling-derived CBF maps are effective in preoperative evaluation of gliomas. Although gliomas with a higher blood flow are more malignant, glioblastomas with a lower blood flow are likely to be more aggressive.
Authors: Katerina Deike; Benedikt Wiestler; Markus Graf; Caroline Reimer; Ralf O Floca; Philipp Bäumer; Philipp Kickingereder; Sabine Heiland; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch Journal: J Neurooncol Date: 2015-10-30 Impact factor: 4.130
Authors: Ronald L Wolf; Jiongjiong Wang; Sumei Wang; Elias R Melhem; Donald M O'Rourke; Kevin D Judy; John A Detre Journal: J Magn Reson Imaging Date: 2005-10 Impact factor: 4.813
Authors: Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon Journal: AJNR Am J Neuroradiol Date: 2005-02 Impact factor: 3.825
Authors: R Soffietti; B G Baumert; L Bello; A Von Deimling; H Duffau; M Frénay; W Grisold; R Grant; F Graus; K Hoang-Xuan; M Klein; B Melin; J Rees; T Siegal; A Smits; R Stupp; W Wick Journal: Eur J Neurol Date: 2010-09 Impact factor: 6.089
Authors: Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley; Rishi Awasthi; Sulaiman Sheriff; Meng Gu; Nuzhat Husain; Sudipta Mohakud; Sanjay Behari; Chandra M Pandey; Ram K S Rathore; Daniel M Spielman; Jeffry R Alger Journal: Neuroradiology Date: 2013-02-02 Impact factor: 2.804
Authors: T B Nguyen; G O Cron; K Perdrizet; K Bezzina; C H Torres; S Chakraborty; J Woulfe; G H Jansen; J Sinclair; R E Thornhill; C Foottit; B Zanette; I G Cameron Journal: AJNR Am J Neuroradiol Date: 2015-07-30 Impact factor: 3.825
Authors: Peter Birner; Maria Piribauer; Ingeborg Fischer; Brigitte Gatterbauer; Christine Marosi; Peter F Ambros; Inge M Ambros; Markus Bredel; Georg Oberhuber; Karl Rössler; Herbert Budka; Adrian L Harris; Johannes A Hainfellner Journal: Brain Pathol Date: 2003-04 Impact factor: 6.508
Authors: Matthew B Pontifex; Kathryn L Gwizdala; Timothy B Weng; David C Zhu; Michelle W Voss Journal: Int J Psychophysiol Date: 2018-10-12 Impact factor: 2.997
Authors: Artem I Batalov; Natalia E Zakharova; Ivan V Chekhonin; Eduard L Pogosbekyan; Anna V Sudarikova; Sergey A Goryainov; Anna A Shulgina; Artem Yu Belyaev; Dmirti Yu Usachev; Igor N Pronin Journal: Diagnostics (Basel) Date: 2022-06-12
Authors: Artem I Batalov; Sergey A Goryaynov; Natalya E Zakharova; Kristina D Solozhentseva; Alexandra V Kosyrkova; Alexander A Potapov; Igor N Pronin Journal: J Clin Med Date: 2021-05-28 Impact factor: 4.241